NRG Oncology recently reported the results of the phase II/III NRG-BN007 clinical trial showing that combining ipilimumab and ...

First patient dosed with CUE-102 for recurrent glioblastoma multiforme (rGBM) at Dana-Farber Cancer Institute (DFCI) BOSTON, ...

Doctors told the Fazenbakers their newborn daughter had a brain tumor that would end her life within weeks. The family got ...

Glioblastoma is a dangerous brain tumour. It affects many people in the United States. Early signs are often missed. Dr.

A clinical trial of an experimental cell therapy shows promising results for glioblastoma patients, with tumors disappearing ...

The tumor, which occurs when supportive cells in the brain grow and divide uncontrollably, is extremely aggressive and deadly. Most patients survive only 14 to 16 months after diagnosis.

Man with deadly glioblastoma shows no signs of disease after taking experimental immunotherapy drug ipilimumab, inspiring a ...

NRG Oncology recently reported the results of the National Cancer Institute sponsored phase II/III NRG-BN007 clinical trial showing that combining ipilimumab and nivolumab with radiation therapy (RT) ...

After decades of limited progress—owing to the difficulty of treating the disease and resultant market risk—glioblastoma ...

A new study, led by researchers at Children's Hospital of Philadelphia (CHOP), identified tiny pieces of messenger RNA that ...

Carol Melvin climbed Snowdon with her daughter Ria's friends to mark the anniversary of her death from brain cancer.